AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
DABIGATRAN ETEXILATE in Zimbabwe
9 products registered with MCAZ — 9 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DAXIMRA 110 CAPSULE; ORAL | 2025/10.2/7249 | MYLAN LABORATORIES LIMITED [OTL] | active | 7 Dec 2030 |
| DAXIMRA 150 CAPSULE; ORAL | 2025/10.2/7250 | MYLAN LABORATORIES LIMITED | active | 7 Dec 2030 |
| DAXIMRA 75 CAPSULE; ORAL | 2025/10.2/7248 | MYLAN LABORATORIES LIMITED [OTL] | active | 7 Dec 2030 |
| HETSOLID 75 CAPSULE | 2025/10.2/6938 | HETERO LABS LTD | active | 31 Dec 2027 |
| DABIFIB 150 CAPSULE | 2022/10.2/6226 | MSN LABORATORIES PRIVATE LIMITED | active | 31 Dec 2027 |
| DABIFIB 75 CAPSULE | 2022/10.2/6228 | MSN LABORATORIES PRIVATE LIMITED | active | 31 Dec 2027 |
| DABIFIB 110 CAPSULE | 2022/10.2/6227 | MSN LABORATORIES PRIVATE LIMITED | active | 31 Dec 2027 |
| HETSOLID 110 CAPSULE | 2025/10.2/6939 | HETERO LABS LTD | active | 31 Dec 2027 |
| HETSOLID 150 CAPSULE | 2025/10.2/6940 | HETERO LABS LTD | active | 31 Dec 2027 |
DABIGATRAN ETEXILATE — MCAZ Registration Details
MCAZ (Zimbabwe) has 9 registered products containing DABIGATRAN ETEXILATE, of which 9 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track DABIGATRAN ETEXILATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.